Cerebrospinal fluid pleocytosis level as a diagnostic predictor? A cross-sectional study
Tóm tắt
Lumbar puncture with quantification of leukocytes and differential count of cellular subsets in the cerebrospinal fluid is a standard procedure in cases of suspected neuroinfectious conditions. However, a number of non-infectious causes may result in a low leukocyte number (0–1000 cells/ml). We wanted to assess the diagnostic diversity of unselected adult patients with pleocytosis in the cerebrospinal fluid. The study is based on data from cerebrospinal fluid (CSF) analyses of all adult patients (15 years or older) admitted to a large university hospital in Denmark during a two-year period (2008–2009). Data from the local patient administrative system supplied with data from patient charts were combined with laboratory data. A total of 5390 cerebrospinal fluid samples from 3290 patients were included. Pleocytosis >5 leucocytes/μl was found in samples from 262 patients of which 106 (40.5%) were caused by infection of the central nervous system (CNS), 20 (7.6%) by infection outside CNS, 79 (30.2%) due to non-infectious neurological diseases, 23 (8.8%) by malignancy, and 34 (13.0%) caused by other conditions. Significantly higher mean CSF leukocytes was found in patients suffering from CNS infection (mean 1135 cells/μl, p-value <0.0001). CNS infection, non-infectious neurological disease, malignancy, and infection outside CNS can cause pleocytosis of the cerebrospinal fluid. Leukocyte counts above 100/μl is mainly caused by CNS infection, whereas the number of differential diagnoses is higher if the CSF leukocyte counts is below 50/μl. These conditions are most commonly caused by non-infectious neurological diseases including seizures.
Tài liệu tham khảo
Michael BD, Sidhu M, Stoeter D, Roberts M, Beeching NJ, Bonington A, Hart IJ, Kneen R, Miller A, Solomon T. Acute central nervous system infections in adults--a retrospective cohort study in the NHS north west region. QJM. 2010;103(10):749–58.
Logan SA, MacMahon E. Viral meningitis. BMJ (Clinical research ed). 2008;336(7634):36–40.
Chadwick DR. Viral meningitis. Br Med Bull. 2005;75-76:1–14.
Mandell LG, Bennett EJ, Raphael D: Principles and practice of infectious diseases. , vol. 1, 7 Philidelphia: Elsevier; 2010.
Kumar R. Aseptic meningitis: diagnosis and management. Indian J Pediatr. 2005;72(1):57–63.
Zunt JR, Baldwin KJ. Chronic and subacute meningitis. Continuum (Minneapolis, Minn). 2012;18(6 Infectious Disease):1290–318.
Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83.
Tumani H, Jobs C, Brettschneider J, Hoppner AC, Kerling F, Fauser S. Effect of epileptic seizures on the cerebrospinal fluid--a systematic retrospective analysis. Epilepsy Res. 2015;114:23–31.
Gradel KO, Nielsen SL, Pedersen C, Knudsen JD, Ostergaard C, Arpi M, Jensen TG, Kolmos HJ, Sogaard M, Lassen AT, et al. Low completeness of bacteraemia registration in the Danish National Patient Registry. PLoS One. 2015;10(6):e0131682.
Henriksen DP, Nielsen SL, Laursen CB, Hallas J, Pedersen C, Lassen AT. How well do discharge diagnoses identify hospitalised patients with community-acquired infections?--a validation study. PLoS One. 2014;9(3):e92891.
Segal BM. Neurosarcoidosis: diagnostic approaches and therapeutic strategies. Curr Opin Neurol. 2013;26(3):307–13.
Lo Monaco A, La Corte R, Caniatti L, Borrelli M, Trotta F. Neurological involvement in north Italian patients with Behcet disease. Rheumatol Int. 2006;26(12):1113–9.
Kawai M, Hirohata S. Cerebrospinal fluid beta(2)-microglobulin in neuro-Behcet’s syndrome. J Neurol Sci. 2000;179(S 1–2):132–9.
Irani DN. Aseptic meningitis and viral myelitis. Neurol Clin. 2008;26(3):635–55. vii-viii
Bremell D, Hagberg L. Clinical characteristics and cerebrospinal fluid parameters in patients with peripheral facial palsy caused by Lyme neuroborreliosis compared with facial palsy of unknown origin (Bell’s palsy). BMC Infect Dis. 2011;11:215.
Chamberlain MC, Glantz MJ. Cerebrospinal fluid-disseminated meningioma. Cancer. 2005;103(7):1427–30.